Scalable Upstream Process Development for the Suspension-Based Production of Lentiviral Vectors for CAR-T Cell Ther 본문 첨부파일 23.01.27-Appl-Note_Scalable-Upstream-Process-Development-for-the-Suspension-based-data.pdf (1.4M) 0회 다운로드 | DATE : 2025-04-15 20:00:05 목록 이전글 Ambr® 15 Cell Culture Generation 2 다음글 Beyond Monoclonal Antibodies - Exploring the Next Generation of Antibody Therapeutics